Genesis Genetics

genesisgenetics.org

Genesis Genetics is the leading global provider of Preimplantation Genetic Diagnosis (PGD) & Preimplantation Genetic Screening (PGS) - providing expert laboratory services for many of the most respected in vitro fertilization (IVF) centers across the country and throughout the world. Founded by a group of world-renowned scientists, Genesis Genetics has pioneered the clinical practice of preimplantation testing of embryos for inherited genetic abnormalities, and our doctors and scientists have performed many of the first and continually successful cases in the world.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Cell and Gene Therapy

TUMORGEN AND PHENOVISTA CAPTURE THE SEEDS THAT DRIVE CANCER METASTASIS

TumorGen Inc. and PhenoVista Biosciences LLC | September 09, 2022

news image

TumorGen Inc., and PhenoVista Biosciences LLC have successfully isolated and characterized metastatic cancer cell clusters from the blood of lung cancer patients’, validating TumorGen’s novel MCCC capture technology. This achievement is a critical milestone in developing anti-metastatic drugs, called “cluster busters,” which will target these cells and prevent cancer metastasis. “Anti-metastatic therapies that can stop tumors fro...

Read More

Medical

ZENFOLD LEVERAGES GINKGO ENZYME SERVICES TO ENABLE VETERINARY ACTIVE INGREDIENT DEVELOPMENT WITH SUSTAINABLE BIOLOGY

PR Newswire | October 17, 2023

news image

Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity, and Zenfold Sustainable Technologies, a company focused on developing and manufacturing specialty ingredients using sustainable technologies and precision fermentation, today announced a collaboration to leverage Ginkgo Enzyme Services in its effort to discover an enzyme critical to the manufac...

Read More

Industrial Impact

XTALPI AND CK LIFE SCIENCES TO COLLABORATE IN AI-EMPOWERED TUMOUR VACCINE RESEARCH AND DEVELOPMENT, OPENING A NEW PARADIGM FOR SCIENTIFIC INNOVATION

XtalPi Inc. | November 25, 2022

news image

XtalPi announced today that they are embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group. XtalPi and CK Life Sciences will leverage their respective expertise to jointly develop a novel AI tumour vaccine R&D platform to improve the discovery and design capabilities of tumour vaccines and accelerate the development of more vaccine types. The goal of this collaboration is to realize precision treatment for patients worldwide. Accordin...

Read More

Medical

FLUENT BIOSCIENCES AND NANOCELLECT ANNOUNCE JOINT COLLABORATION TO IMPROVE RESOLUTION OF SINGLE-CELL RNA SEQUENCING ANALYSIS OF RARE CELL POPULATIONS

Fluent BioSciences | June 18, 2022

news image

Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, and NanoCellect Biomedical, Inc., a leader in the development and manufacturing of innovative and affordable solutions for cell sorting, jointly announced a collaboration to improve resolution and efficiency of single-cell RNA sequencing (scRNA-seq) analysis of rare cell populations. Single-cell researchers are increasingly requiring scalable, flexible and ...

Read More
news image

Cell and Gene Therapy

TUMORGEN AND PHENOVISTA CAPTURE THE SEEDS THAT DRIVE CANCER METASTASIS

TumorGen Inc. and PhenoVista Biosciences LLC | September 09, 2022

TumorGen Inc., and PhenoVista Biosciences LLC have successfully isolated and characterized metastatic cancer cell clusters from the blood of lung cancer patients’, validating TumorGen’s novel MCCC capture technology. This achievement is a critical milestone in developing anti-metastatic drugs, called “cluster busters,” which will target these cells and prevent cancer metastasis. “Anti-metastatic therapies that can stop tumors fro...

Read More
news image

Medical

ZENFOLD LEVERAGES GINKGO ENZYME SERVICES TO ENABLE VETERINARY ACTIVE INGREDIENT DEVELOPMENT WITH SUSTAINABLE BIOLOGY

PR Newswire | October 17, 2023

Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity, and Zenfold Sustainable Technologies, a company focused on developing and manufacturing specialty ingredients using sustainable technologies and precision fermentation, today announced a collaboration to leverage Ginkgo Enzyme Services in its effort to discover an enzyme critical to the manufac...

Read More
news image

Industrial Impact

XTALPI AND CK LIFE SCIENCES TO COLLABORATE IN AI-EMPOWERED TUMOUR VACCINE RESEARCH AND DEVELOPMENT, OPENING A NEW PARADIGM FOR SCIENTIFIC INNOVATION

XtalPi Inc. | November 25, 2022

XtalPi announced today that they are embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group. XtalPi and CK Life Sciences will leverage their respective expertise to jointly develop a novel AI tumour vaccine R&D platform to improve the discovery and design capabilities of tumour vaccines and accelerate the development of more vaccine types. The goal of this collaboration is to realize precision treatment for patients worldwide. Accordin...

Read More
news image

Medical

FLUENT BIOSCIENCES AND NANOCELLECT ANNOUNCE JOINT COLLABORATION TO IMPROVE RESOLUTION OF SINGLE-CELL RNA SEQUENCING ANALYSIS OF RARE CELL POPULATIONS

Fluent BioSciences | June 18, 2022

Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, and NanoCellect Biomedical, Inc., a leader in the development and manufacturing of innovative and affordable solutions for cell sorting, jointly announced a collaboration to improve resolution and efficiency of single-cell RNA sequencing (scRNA-seq) analysis of rare cell populations. Single-cell researchers are increasingly requiring scalable, flexible and ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us